A comparison of weekly versus 3-weekly cisplatin during adjuvant radiotherapy for high-risk head and neck cancer.
Oosting SF, Chen TWW, Huang SH, Wang L, Waldron J, Gilbert R, Goldstein D, Halmos GB, Witjes MJH, Gietema JA, O'Sullivan B, Langendijk JA, Siu LL, Hansen AR.
Oosting SF, et al. Among authors: halmos gb.
Oral Oncol. 2016 Aug;59:43-49. doi: 10.1016/j.oraloncology.2016.05.016.
Oral Oncol. 2016.
PMID: 27424181
Free article.